Study of a new heart valve for severe pulmonary valve leakage
Part of Heart & circulation clinical trials.
This study tests a new less-invasive heart valve (VenusP-Valve) for people whose own pulmonary valve is leaking severely. If you qualify, you could get the new valve without open-heart surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Weigh at least 55 pounds (25 kg)
- Be 12 years old or older
- Have severe backward leakage of blood through your pulmonary valve (without significant narrowing)
- Be willing to come back for all follow-up visits after the procedure
- Not have an active heart infection, blood clotting disorder, or other major condition making the procedure risky
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new type of replacement valve for children who need a new pulmonary valve (the valve between the heart and lungs). Researchers want to see if the valve works safely and well in real-world use.
This observational study follows people who need a pulmonary valve treatment, to see how the Venus P-Valve works in real-world care. It may help doctors understand which patients benefit and how outcomes change over time.
This study observes patients who receive a new type of replacement heart valve (called the PULSTA valve) placed inside their own pulmonary valve. It helps doctors learn how well the valve works and how safe it is in everyday medical care.
This study tests whether a new type of heart valve made from your own tissue (an “autologous” valve) can be placed through a catheter safely in adults with leaking and pressure-related problems in the lung heart valve area. If it works well, it could offer a safer option for people who need treatment for pulmonary valve problems.
This study tests a new device called the Vesalius TMVr system to fix a leaky mitral valve without open-heart surgery. It's for people with severe mitral regurgitation who are not good candidates for surgery.
This trial tests a new device called Laplace TTVR to replace a leaky tricuspid valve in the heart without open surgery. It is for people with severe symptoms despite medical treatment.
Hear when a new Pulmonary Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.